ConjuChem Biotechnologies

ConjuChem Creates New Next-Generation Drugs Using Unique Long-Acting Therapeutic Peptides. The Foundation of All ConjuChem Compounds Lies in Bioconjugation Platforms Known as Drug Affinity Complex (DAC) and Preformed Conjugated Drug Affinity Complex (PC-DAC™)™. When Applied to a Given Peptide, DAC™ and PC-DAC™ Can Generate New Drugs with Similar Therapeutic Activity but Significantly Longer Duration of Action and Improved Safety.